Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Vaxcyte Inc (NASDAQ: PCVX) closed at $78.89 down -1.26% from its previous closing price of $79.90. In other words, the price has decreased by -$1.26 from its previous closing price. On the day, 1.15 million shares were traded. PCVX stock price reached its highest trading level at $80.59 during the session, while it also had its lowest trading level at $77.66.
Ratios:
For a deeper understanding of Vaxcyte Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.42 and its Current Ratio is at 17.42. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on December 07, 2023, initiated with a Buy rating and assigned the stock a target price of $69.
Needham reiterated its Buy rating for the stock on January 03, 2023, while the target price for the stock was revised from $52 to $58.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 23 ’24 when PICKERING GRANT sold 15,000 shares for $84.26 per share. The transaction valued at 1,263,912 led to the insider holds 478,888 shares of the business.
GUGGENHIME ANDREW sold 8,000 shares of PCVX for $649,325 on Jul 18 ’24. The PRESIDENT AND CFO now owns 96,720 shares after completing the transaction at $81.17 per share. On Jul 16 ’24, another insider, Cowan Elvia, who serves as the SVP, FINANCE of the company, sold 5,000 shares for $85.00 each. As a result, the insider received 425,000 and left with 12,723 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PCVX now has a Market Capitalization of 8910783488 and an Enterprise Value of 7233637376.
Stock Price History:
Over the past 52 weeks, PCVX has reached a high of $87.71, while it has fallen to a 52-week low of $44.20. The 50-Day Moving Average of the stock is 3.43%, while the 200-Day Moving Average is calculated to be 20.43%.
Shares Statistics:
For the past three months, PCVX has traded an average of 727.21K shares per day and 733360 over the past ten days. A total of 108.80M shares are outstanding, with a floating share count of 103.40M. Insiders hold about 4.96% of the company’s shares, while institutions hold 106.45% stake in the company. Shares short for PCVX as of 1721001600 were 11873036 with a Short Ratio of 16.33, compared to 1718323200 on 9680523. Therefore, it implies a Short% of Shares Outstanding of 11873036 and a Short% of Float of 12.640001000000002.
